SynthesisJournal of immunology research2018

Monoclonal Antibodies versus Histone Deacetylase Inhibitors in Combination with Bortezomib or Lenalidomide plus Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma: An Indirect-Comparison Meta-Analysis of Randomized Controlled Trials.

Yanhua Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.